Table 2.
Distribution of serum compound concentrations in the adults study population (20 years and older), NHANES 1999–2002.
| n | GM (SE) | |
|---|---|---|
| ∑ PCBs lipid adj (ng/g) | 2175 | 82.13 (2.55) |
| ∑ Non-dioxin-like lipid adj (ng/g) | 2413 | 81.89 (2.54) |
| PCB138 lipid adj (ng/g) | 2422 | 23.23 (0.73) |
| PCB153 lipid adj (ng/g) | 2422 | 33.95 (1.06) |
| PCB180 lipid adj (ng/g) | 2424 | 23.16 (0.76) |
| ∑ Dioxin-like PCBs lipid adj (pg/g) | 2202 | 38.31 (1.29) |
| PCB 126 lipid adj (pg/g) | 2215 | 18.72 (0.69) |
| PCB 169 lipid adj pg/g) | 2216 | 16.19 (0.51) |
| ∑ PCDDs lipid adj (pg/g) | 2115 | 370.90 (14.02) |
| 1,2,3,6,7,8-hxcdd. lipid adj (pg/g) | 2215 | 21.45 (1.15) |
| 1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin lipid adj (pg/g) | 2203 | 37.78 (1.57) |
| 1,2,3,4,6,7,8,9-Octachlorodibenzo-p-dioxin lipid adj (pg/g) | 2175 | 296.91 (10.90) |
| PCDF | ||
| 1,2,3,4,6,7,8-Heptachlorodibenzofuran (pg/g) | 2090 | 7.70 (0.29) |
| TEQDL lipid adj (pg/g) | 1976 | 6.01 (0.23) |
| TEQPCB lipid adj (pg/g) | 2202 | 2.53 (0.09) |